IP Library Granted Patent US 12,466,981
Granted Patent B2
US 12,466,981 · App. 18/005,377 · Granted Nov 11, 2025

Curable two-part adhesive composition

Inventors: Patxi Garra (Barcelona, ES); Marta Rodriguez Ble (Barcelona, ES); Jordi Solera Sendra (Barcelona, ES); Marc Escriba Pla (Barcelona, ES)
Assignee: BOSTIK SA
C09J133/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,466,981
App. No.
18/005,377
Granted
Nov 11, 2025
Kind
B2
Abstract

The present invention refers to a curable two-part adhesive composition comprising a first part comprising one or more cyanoacrylate monomer(s), one or more (metha)acrylate monomer(s), a per-compound and, optionally, additives to control viscosity and rheology; and a second part comprising: a non-reactive diluent and a transition metal catalyst, and optionally an electron rich initiator for cyanoacrylates. It also relates to a syringe or a cartridge comprising said two-part curable composition, to the use of such composition for bonding substrates, to the use of such composition filling depressions, cracks or holes in a substrate or between substrates to a method for bonding substrates using said composition, and to a repair method for filling depressions, cracks or holes in a substrate or between substrates using said composition.

Claims (69)

1 . A two-part curable composition, characterized in that it comprises:

a) a first part (part A) comprising:

i. at least 50 wt. % of one or more cyanoacrylate monomer(s),

ii. at least 1 wt. % of one or more (meth)acrylic monomer(s), and

iii. at least 1 wt. % of a per-compound,

wherein the wt. % is based on the total weight of the first part of the composition,

b) a second part (part B) comprising:

i. at least 50 wt. % of a non-reactive diluent, and

ii. from 0.001 wt. % to 2 wt. % of a transition metal catalyst, expressed as the content of the transition metal,

wherein the wt. % is based on the total weight of the second part of the composition, wherein the volume ratio between the first part and the second part ranges from 4:1 to 10:1, with the proviso that the second part does not comprise any vinylic monomer(s).

2 . The two-part curable composition according to claim 1 , characterized in that the (meth)acrylic monomer(s) of Part A of the two-part curable composition is selected from the group consisting of:

i. a compound of general formula (III)

CH 2 ═CR 3 (CO 2 R 4 )  (III)

wherein R 3 represents methyl or H, and R 4 is a hydrogen atom, a C 1 -C 8 linear or branched alkyl, a C 2 -C 6 linear or branched alkoxyalkyl, a furfuryl or an isobornyl group;

ii. polyfunctional (meth)acrylic esters, and

iii. mixtures thereof.

3 . The two-part curable composition according to claim 1 , characterized in that the first part of the composition further contains one or more additives selected from the group consisting of stabilizing agents, adhesion promoters, accelerating agents, thixotropic agents, thickening agents, toughening agents, plasticizers, antioxidants, pigments, colorants, and mixtures thereof.

4 . The two-part curable composition according to claim 3 , characterized in that the first part of the composition comprises one or more stabilizing agents selected from the group consisting of radical stabilizing agents, acid stabilizing agents, and mixtures thereof.

5 . The two-part curable composition according to claim 1 , characterized in that the non-reactive diluent is a plasticizer.

6 . The two-part curable composition according to claim 1 , characterized in that the transition metal catalyst is a transition metal salt.

7 . The two-part curable composition according to claim 6 , characterized in that the transition metal salt is selected from the group consisting of Cu(ACN) 4 BF 4 , Cu(ACN) 4 PF 6 , Cu(BF 4 ) 2 , Cu (II) acetate, CU (II) octoate, Cu(II) benzoate, Cu (II) chlorate, Cu (II) carbonate, Cu(II) acetylacetonate, Cu (I) trifluoromethanesulfonate, Cu (II) sulfate, Fe (II) triflate, ferrocene, Fe (II) tetrafluorobotare, MnClO 4 , Co naphtenate, and Co tetrafluoroborate.

8 . The two-part curable composition according to claim 1 , characterized in that the second part of the composition comprises an electron rich initiating species for cyanoacrylates.

9 . The two-part curable composition according to claim 1 , characterized in that the (meth)acrylic monomer(s) of Part A of the two-part curable composition is selected from the group consisting of:

a compound of general formula (III)

CH 2 ═CR 3 (CO 2 R 4 )  (III)

wherein R 3 represents methyl or H, and R 4 is a hydrogen atom, a C 1 -C 8 linear or branched alkyl, a C 2 -C 6 linear or branched alkoxyalkyl, a furfuryl or an isobornyl group;

a polyfunctional (meth)acrylic ester selected from the group consisting of butanediol di(meth)acrylate, hexanediol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethyleneglycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, triethylene oxide dimethacrylate, tris-(2-hydroxyethyl) isocyanurate triacrylate, tricyclodecane dimethanol diacrylate, trimethylolpropane tri(meth)acrylate (TMPTA), ethoxylated trimethylolpropane tri(meth)acrylate, neopentylglycol diacrylate, pentaerythritol tetraacrylate (PETA), pentaerythritol tetramethacrylate (PETMA), dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, bisphenol-A-diacrylate, bisphenol-A-dimethacrylate, ethoxylated bisphenol-A-diacrylate, propoxylated bisphenol-A-diacrylate, and mixtures thereof; (meth)acrylic functionalized oligomers and (meth)acrylic functionalized resins; and

mixtures thereof.

10 . The two-part curable composition according to claim 1 , characterized in that the (meth)acrylic monomer(s) of Part A of the two-part curable composition is selected from the group consisting of:

a compound of general formula (III)

CH 2 ═CR 3 (CO 2 R 4 )  (III)

wherein R 3 represents methyl or H, and R 4 is a hydrogen atom, a C 1 -C 8 linear or branched alkyl, a C 2 -C 6 linear or branched alkoxyalkyl, a furfuryl or an isobornyl group;

a polyfunctional (meth)acrylic ester selected from the group consisting of butanediol di(meth)acrylate, hexanediol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethyleneglycol di(meth)acrylate, polyethylene glycol di(meth)acrylate, triethylene oxide dimethacrylate, tris-(2-hydroxyethyl) isocyanurate triacrylate, tricyclodecane dimethanol diacrylate, trimethylolpropane tri(meth)acrylate (TMPTA), ethoxylated trimethylolpropane tri(meth)acrylate, neopentylglycol diacrylate, pentaerythritol tetraacrylate (PETA), pentaerythritol tetramethacrylate (PETMA), dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, bisphenol-A-diacrylate, bisphenol-A-dimethacrylate, ethoxylated bisphenol-A-diacrylate, propoxylated bisphenol-A-diacrylate, and mixtures thereof; and

mixtures thereof.

11 . The two-part curable composition according to claim 1 , characterized in that it comprises:

a) a first part (Part A) comprising:

i. from 50 wt. % to 99 wt. % of one or more cyanoacrylate monomer(s),

ii. at least 1 wt. % of one or more (meth)acrylic monomer(s), and

iii. at least 1 wt. % of a per-compound,

wherein the wt. % is based on the total weight of the first part of the composition,

b) a second part (Part B) comprising:

i. from 50 wt. % to 99.9 wt. %, of a non-reactive diluent, and

ii. from 0.001 wt. % to 2 wt. % of a transition metal catalyst, expressed as the content of the transition metal,

wherein the wt. % is based on the total weight of the second part of the composition, wherein the volume ratio between the first part and the second part ranges from 4:1 to 10:1, with the proviso that the second part does not comprise any vinylic monomer(s).

12 . The two-part curable composition according to claim 1 , characterized in that it comprises:

a) a first part (Part A) comprising:

i. at least 50 wt. % of one or more cyanoacrylate monomer(s);

ii. from 1 wt. % to 10 wt. % of a (meth)acrylate monomer or monomers;

iii. from 1 wt. % to 10 wt. % of a per-compound;

iv. from 0.001 wt. % to 0.2 wt. % of stabilizing agent(s);

v. from 2 wt. % to 10 wt. % by weight of thixotropic agent(s); and

vi. from 2 wt. % to 10 wt. % by weight of thickening agent(s);

wherein the wt. % is based on the total weight of the first part of the composition,

b) a second part (Part B) comprising:

i. at least 50 wt. % of at least one non-reactive diluent;

ii. from 0.001 wt. % to 2 wt. % of a transition metal catalyst, expressed as the content of the transition metal,

iii. from 0.1 wt. % to 2 wt. % of an electron rich initiator compound;

iv. from 2 wt. % to 15 wt. % of thickening agent(s); and

v. from 2 wt. % to 8 wt. % of thixotropic agent(s);

wherein the wt. % is based on the total weight of the second part of the composition, wherein the volume ratio between the first part and the second part ranges from 4:1 to 10:1, with the proviso that the second part does not comprise any vinylic monomer(s).

13 . A syringe or a cartridge comprising the two-part curable cyanoacrylate composition of claim 1 .

14 . A method for bonding substrates, characterized in that it comprises the steps of:

1) mixing together the two-part curable composition of claim 1 ,

2) applying the mix of Step 1) to at least one of the substrates, and

3) mating together the substrates for a time sufficient to permit an adhesive bond to form between the mated substrates.

15 . A repair method for filling depressions, cracks or holes in a substrate or between substrates, characterized in that it comprises the steps of:

1) mixing together the two-part curable composition of claim 1 ,

2) applying the mix of Step 1) into a depression, crack or hole of a substrate or on the upper part of a substrate, and optionally,

3) assembling a second substrate atop the first substrate.

Assignments (2)
CHANGE OF ADDRESS Recorded Jul 30, 2025
From: BOSTIK SA
To: BOSTIK SA
Reel/Frame 072277/0238 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2023
From: GARRA, PATXI; RODRIGUEZ BLE, MARTA; SOLERA SENDRA, JORDI; ESCRIBA PLA, MARC
To: BOSTIK SA
Reel/Frame 062367/0536 →
Priority Claims (1)
EP 20305840 · Jul 22, 2020 · regional
Continuity (1)
Related Publication 20230265320A1 · Aug 24, 2023
References Cited (21)
US 3260637A · Bramer · 1966 [cited by applicant]
US 3836377A · Delahunty · 1974 [cited by applicant]
US 4460758A · Peiffer et al. · 1984 [cited by applicant]
US 5066743A · Okamoto et al. · 1991 [cited by applicant]
US 5110392A · Ito et al. · 1992 [cited by applicant]
US 6001213A · Liu · 1999 [cited by applicant]
US 8981027B2 · Ward et al. · 2015 [cited by applicant]
US 20030191248A1 · Ryan et al. · 2003 [cited by applicant]
US 20050000646A1 · Ryan et al. · 2005 [cited by applicant]
US 20110196091A1 · Zhang et al. · 2011 [cited by applicant]
US 20130111036A1 · Ozawa et al. · 2013 [cited by applicant]
US 20140275419A1 · Ward · 2014 [cited by examiner]
US 20170335151A1 · Ward · 2017 [cited by examiner]
US 20200081750A1 · Kuruvilla et al. · 2020 [cited by applicant]
US 20200082060A1 · Steele · 2020 [cited by applicant]
WO WO0118068A1 · 2001 [cited by examiner]
WO 2013111036A1 · 2013 [cited by applicant]
WO 2015059644A1 · 2015 [cited by applicant]
WO 2020082060A1 · 2020 [cited by applicant]
ISA/EP; International Search Report and Written Opinion for International Patent Application No. PCT/EP2021/070278 dated Oct. 15, 2021, 9 pages. [cited by applicant]
Garra et al., Prog. Pol. Sci., 2019, 94, 33. [cited by applicant]